Neogen Free Cash Flow (FCF) History (NEOG)
Neogen reported $31.9M in free cash flow for fiscal 2026, an increase of $78.3M from the previous fiscal year, with a free cash flow margin of 3.66%.
View full Neogen company overviewNeogen free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2026 | 2026-05-31 | $31.9M | $78.3M | — | +3.66% |
| 2025 | 2025-05-31 | −$46.4M | $29.7M | — | −5.19% |
| 2024 | 2024-05-31 | −$76.1M | −$51.4M | — | −8.23% |
| 2023 | 2023-05-31 | −$24.7M | −$68.3M | — | −3.01% |
| 2022 | 2022-05-31 | $43.6M | −$10.8M | −19.80% | +8.27% |
| 2021 | 2021-05-31 | $54.4M | −$7.4M | −12.05% | +11.61% |
| 2020 | 2020-05-31 | $61.8M | $12.6M | +25.71% | +14.78% |
| 2019 | 2019-05-31 | $49.2M | $996,000 | +2.07% | +11.87% |
| 2018 | 2018-05-31 | $48.2M | $2.5M | +5.45% | +12.11% |
| 2017 | 2017-05-31 | $45.7M | $24.6M | +116.48% | +12.75% |
| 2016 | 2016-05-31 | $21.1M | −$13.1M | −38.23% | +6.57% |
| 2015 | 2015-05-31 | $34.2M | $24.0M | +237.51% | +12.07% |
| 2014 | 2014-05-31 | $10.1M | −$7.5M | −42.68% | +4.09% |
| 2013 | 2013-05-31 | $17.7M | −$3.1M | −14.98% | +8.51% |
| 2012 | 2012-05-31 | $20.8M | −$270,000 | −1.28% | +11.29% |
| 2011 | 2011-05-31 | $21.0M | −$1.5M | −6.69% | +12.19% |
| 2010 | 2010-05-31 | $22.6M | — | — | +16.05% |
Neogen quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2026 | 2026-05-31 | $26.2M | $25.9M | +8633.33% | +11.63% |
| Q3 2026 | 2026-02-28 | $11.1M | $24.5M | — | +5.24% |
| Q2 2026 | 2025-11-30 | $7.8M | −$15.3M | −66.34% | +3.46% |
| Q1 2026 | 2025-08-31 | −$13.1M | $43.2M | — | −6.29% |
| Q4 2025 | 2025-05-31 | $300,000 | −$2.3M | −88.24% | +0.13% |
| Q3 2025 | 2025-02-28 | −$13.4M | $48.9M | — | −6.09% |
| Q2 2025 | 2024-11-30 | $23.1M | $31.8M | — | +9.99% |
| Q1 2025 | 2024-08-31 | −$56.3M | −$48.7M | — | −25.97% |
| Q4 2024 | 2024-05-31 | $2.5M | −$62.9M | −96.10% | +1.08% |
| Q3 2024 | 2024-02-29 | −$62.3M | −$30.1M | — | −27.24% |
| Q2 2024 | 2023-11-30 | −$8.7M | $22.1M | — | −3.79% |
| Q1 2024 | 2023-08-31 | −$7.6M | $19.5M | — | −3.33% |
| Q4 2023 | 2023-05-31 | $65.5M | $57.6M | +733.70% | +27.07% |
| Q3 2023 | 2023-02-28 | −$32.2M | −$32.2M | — | −14.76% |
| Q2 2023 | 2022-11-30 | −$30.8M | −$44.7M | — | −13.40% |
| Q1 2023 | 2022-08-31 | −$27.1M | −$49.1M | — | −20.51% |
| Q4 2022 | 2022-05-31 | $7.9M | −$6.8M | −46.40% | +5.60% |
| Q3 2022 | 2022-02-28 | −$65,000 | −$3.4M | — | −0.05% |
| Q2 2022 | 2021-11-30 | $13.9M | −$1.6M | −10.54% | +10.66% |
| Q1 2022 | 2021-08-31 | $21.9M | $1.0M | +4.93% | +17.08% |
| Q4 2021 | 2021-05-31 | $14.7M | −$3.2M | −18.15% | +11.50% |
| Q3 2021 | 2021-02-28 | $3.3M | −$13.0M | −79.74% | +2.82% |
| Q2 2021 | 2020-11-30 | $15.5M | $5.1M | +49.25% | +13.52% |
| Q1 2021 | 2020-08-31 | $20.9M | $3.6M | +21.08% | +19.10% |
| Q4 2020 | 2020-05-31 | $17.9M | −$195,000 | −1.08% | +16.41% |
| Q3 2020 | 2020-02-29 | $16.3M | $11.0M | +211.23% | +16.28% |
| Q2 2020 | 2019-11-30 | $10.4M | −$1.3M | −10.97% | +9.66% |
| Q1 2020 | 2019-08-31 | $17.3M | $3.1M | +21.79% | +17.01% |
| Q4 2019 | 2019-05-31 | $18.1M | $187,000 | +1.04% | +16.48% |
| Q3 2019 | 2019-02-28 | $5.2M | −$8.1M | −60.66% | +5.35% |
| Q2 2019 | 2018-11-30 | $11.7M | $9.0M | +326.66% | +10.92% |
| Q1 2019 | 2018-08-31 | $14.2M | −$92,000 | −0.65% | +14.22% |
| Q4 2018 | 2018-05-31 | $17.9M | $4.4M | +32.54% | +16.56% |
| Q3 2018 | 2018-02-28 | $13.3M | $4.4M | +49.65% | +13.99% |
| Q2 2018 | 2017-11-30 | $2.7M | −$3.7M | −57.69% | +2.72% |
| Q1 2018 | 2017-08-31 | $14.3M | −$2.6M | −15.29% | +15.13% |
| Q4 2017 | 2017-05-31 | $13.5M | $9.3M | +218.48% | +14.14% |
| Q3 2017 | 2017-02-28 | $8.9M | $5.1M | +132.27% | +10.04% |
| Q2 2017 | 2016-11-30 | $6.5M | −$2.8M | −30.06% | +7.14% |
| Q1 2017 | 2016-08-31 | $16.8M | $13.1M | +345.36% | +20.12% |
| Q4 2016 | 2016-05-31 | $4.2M | −$3.3M | −43.91% | +4.71% |
| Q3 2016 | 2016-02-29 | $3.8M | −$4.1M | −51.93% | +4.98% |
| Q2 2016 | 2015-11-30 | $9.3M | −$1.5M | −13.78% | +11.64% |
| Q1 2016 | 2015-08-31 | $3.8M | −$4.1M | −52.25% | +5.05% |
| Q4 2015 | 2015-05-31 | $7.6M | $7.3M | +2339.68% | +9.62% |
| Q3 2015 | 2015-02-28 | $7.9M | $4.4M | +122.20% | +11.62% |
| Q2 2015 | 2014-11-30 | $10.7M | $8.0M | +287.87% | +15.70% |
| Q1 2015 | 2014-08-31 | $7.9M | $4.4M | +128.27% | +11.71% |
| Q4 2014 | 2014-05-31 | $310,000 | −$4.4M | −93.47% | +0.46% |
| Q3 2014 | 2014-02-28 | $3.6M | −$1.4M | −27.78% | +5.77% |
| Q2 2014 | 2013-11-30 | $2.8M | −$2.7M | −49.09% | +4.65% |
| Q1 2014 | 2013-08-31 | $3.5M | $946,000 | +37.52% | +5.92% |
| Q4 2013 | 2013-05-31 | $4.7M | $5.0M | — | +8.48% |
| Q3 2013 | 2013-02-28 | $5.0M | −$185,000 | −3.60% | +9.70% |
| Q2 2013 | 2012-11-30 | $5.4M | $2.7M | +97.42% | +10.73% |
| Q1 2013 | 2012-08-31 | $2.5M | $8.0M | — | +5.07% |
| Q4 2012 | 2012-05-31 | −$278,000 | −$2.7M | — | −0.57% |
| Q3 2012 | 2012-02-29 | $5.1M | $2.7M | +107.85% | +11.44% |
| Q2 2012 | 2011-11-30 | $2.8M | −$3.4M | −55.27% | +6.14% |
| Q1 2012 | 2011-08-31 | −$5.5M | −$15.5M | — | −11.99% |
| Q4 2011 | 2011-05-31 | $2.4M | — | — | +5.59% |
| Q3 2011 | 2011-02-28 | $2.5M | — | — | +5.85% |
| Q2 2011 | 2010-11-30 | $6.2M | — | — | +14.03% |
| Q1 2011 | 2010-08-31 | $10.0M | — | — | +23.23% |
Neogen free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from $54.4M to $31.9M, a compound annual decline of 10.12%. Neogen's latest reported quarter, Q4 2026, generated $26.2M in free cash flow, an increase of 8633.33% year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Neogen filings at SEC.gov ↗